Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.190
+0.120 (5.80%)
At close: Jun 26, 2026, 4:00 PM EDT
2.250
+0.060 (2.74%)
Pre-market: Jun 29, 2026, 8:51 AM EDT
CNTB Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CNTB stock have an average target of 7.21, with a low estimate of 4.00 and a high estimate of 10. The average target predicts an increase of 229.22% from the current stock price of 2.19.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CNTB stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 7 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $7 | Buy | Initiates | $7 | +219.63% | Jun 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +219.63% | Jun 25, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $6 | Buy | Maintains | $6 | +173.97% | Jun 18, 2026 |
| BTIG | BTIG | Buy Maintains $10 | Buy | Maintains | $10 | +356.62% | Jun 18, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $4 | Buy | Initiates | $4 | +82.65% | May 21, 2026 |
Financial Forecast
Revenue This Year
5.70M
from 64.00K
Increased by 8,810.60%
Revenue Next Year
10.74M
from 5.70M
Increased by 88.38%
EPS This Year
-0.15
from -0.14
EPS Next Year
-0.14
from -0.15
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.0M | 40.9M | |
| Avg | 5.7M | 10.7M | |
| Low | 196,017 | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 23,287.2% | 616.5% | |
| Avg | 8,810.6% | 88.4% | |
| Low | 206.3% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.12 | -0.07 | |
| Avg | -0.15 | -0.14 | |
| Low | -0.17 | -0.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.